Pravastatin Sandoz

Pravastatin Sandoz Dosage/Direction for Use

pravastatin

Manufacturer:

Lek Pharma

Distributor:

Zuellig Pharma

Marketer:

Sandoz
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Dosage/Direction for Use
Prior to initiating pravastatin sodium, secondary causes of hypercholesterolaemia should be excluded and patients should be placed on a standard lipid-lowering diet which should be continued during treatment.
Pravastatin is administered orally once daily preferably in the evening with or without food.
Hypercholesterolaemia: The recommended dose range is 10-40 mg pravastatin sodium once daily.
The therapeutic response is seen within a week and the full effect of a given dose occurs within four weeks, therefore periodic lipid determinations should be performed and the dose adjusted accordingly.
The maximum daily dose is 40 mg pravastatin sodium.
Cardiovascular prevention: In all preventive morbidity and mortality trials, the only studied starting and maintenance dose was 40 mg pravastatin sodium daily.
Dose after transplantation: Following organ transplantation a starting dose of 20 mg per day is recommended in patients receiving immunosuppressive therapy (see Interactions). Depending on the response of the lipid parameters, the dose may be adjusted up to 40 mg under close medical supervision (see Interactions).
Paediatric population: Children and adolescents (8-18 years of age) with heterozygous familial hypercholesterolaemia: The recommended dose range is 10-20 mg once daily between 8 and 13 years of age as doses greater than 20 mg have not been studied in this population and 10-40 mg daily between 14 and 18 years of age (for children and adolescent females of child-bearing potential, see Use in Pregnancy & Lactation; for results of the study see Pharmacology: Pharmacodynamics under Actions).
Elderly patients: There is no dose adjustment necessary in these patients unless there are predisposing risk factors (see Precautions).
Renal or hepatic impairment: A starting dose of 10 mg a day is recommended in patients with moderate or severe renal impairment or significant hepatic impairment. The dose should be adjusted according to the response of lipid parameters and under medical supervision.
Concomitant therapy: The lipid lowering effects of pravastatin on total cholesterol and LDL-cholesterol are enhanced when combined with a bile acid-binding resin (e.g. colestyramine, colestipol). Pravastatin should be given either one hour before or at least four hours after the resin (see Interactions).
For patients taking ciclosporin with or without other immunosuppressive medicinal products, treatment should begin with 20 mg of pravastatin once daily and titration to 40 mg should be performed with caution (see Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in